The sterile solution of purified capsular polysaccharides from S. pneumoniae serotypes 3, 6A, 7F, 8, 9N, 10A, 11A, 12F, 15A, 15B (de-O-acetylated prior to conjugation), 16F, 17F, 19A, 20A, 22F, 23A, 23B, 24F, 31, 33F, and 35B individually conjugated to CRM197 carrier protein.
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J07 VACCINES
J07A BACTERIAL VACCINES
J07AL Pneumococcal vaccines
J07AL02 Pneumococcus, purified polysaccharides antigen conjugated
D13153 Pneumococcal 21-valent conjugate vaccine <JP/US>
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
63 Biological preparations
631 Vaccines
6311 Bacterial vaccines
D13153 Pneumococcal 21-valent conjugate vaccine
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D13153
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D13153
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D13153
